Comprehensive phosphorus management preserves residual renal function, considers dialysis modality, and minimizes intervention burden.

Akebia Therapeutics (NASDAQ:AKBA) executives outlined the company’s commercial priorities and pipeline plans at the ...

INDICATION XPHOZAH (tenapanor), 30 mg BID, is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response ...

A common iron mineral hiding in soil turns out to be far better at trapping carbon than scientists realized. Its surface ...

The global market for Ternary Cathode NCM Material was valued at USD 9156 Million in the year 2024 and is projected to reach a revised size of USD 28650 Million by 2031, growing at a CAGR of 20.2% ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.